home / stock / hcwb / hcwb news

HCWB News and Press, HCW Biologics Inc. From 03/28/22

Stock Information
Company Name: HCW Biologics Inc.
Stock Symbol: HCWB
Market: NASDAQ
Website: hcwbiologics.com
Menu
HCWB HCWB Quote HCWB Short HCWB News HCWB Articles HCWB Message Board
Get HCWB Alerts

News, Short Squeeze, Breakout and More Instantly...
HCWB - HCW Biologics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights for 2021

$56 Million IPO Completed in July 2021 Expected to Fund Operating Expenses through 2023 FDA Clearance for Initial Clinical Trials in Two Difficult-to-Treat Cancer Indications Publication of Three Pivotal Scientific Papers in Peer-Reviewed Journals MIRAMAR, Fla., Ma...
HCWB - HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest

MIRAMAR, Fla., March 24, 2022 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link betw...

HCWB - Masonic Cancer Center at the University of Minnesota Receives FDA Clearance to Proceed with Phase 1 Clinical Trial in Solid Tumors for HCW9218, HCW Biologics' Novel Bifunctional Fusion Protein

MIRAMAR, Fla., Jan. 24, 2022 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between inflammation and age-related d...

HCWB - HCW Biologics Inc. Announces its Lead Product Candidate Shown to Augment Anti-Tumor Activity and Reduce Side Effects of Chemotherapy Regimens

MIRAMAR, Fla., Jan. 20, 2022 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammatio...
HCWB - HCW Biologics' Founder and CEO Dr. Hing C. Wong Participating in Cambridge Healthtech Institute's Annual PepTalk Conference 2022

MIRAMAR, Fla., Jan. 19, 2022 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCW Biologics” or the “Company”) (NASDAQ: HCWB), a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link betwe...

HCWB - HCW Biologics to Participate in H.C. Wainwright BioConnect Conference January 10 - 13, 2022

MIRAMAR, Fla., Jan. 06, 2022 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between chronic, low-grade inflammation...

HCWB - HCW Biologics' Founder and CEO Dr. Hing C. Wong Named Weaver H. Gaines Entrepreneur of the Year

MIRAMAR, Fla., Dec. 13, 2021 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link betwe...
HCWB - HCW Biologics reports Q3 results

HCW Biologics (NASDAQ:HCWB): Q3 Net Loss of $4.1M Cash balance of $15.1M Press Release For further details see: HCW Biologics reports Q3 results

HCWB - HCW Biologics Reports Third Quarter Financial Results and Recent Business Highlights

MIRAMAR, Fla., Nov. 12, 2021 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), an innovative biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting th...

HCWB - SA readers love Shiba Inu, GlobalFoundries; walk away from Mandiant, Rite Aid

Investor interest in Naked Wines (OTCQX:NWINF), HCW Biologics (NASDAQ:HCWB) and cryptocurrency Shiba Inu (SHIB-USD) is surging, an analysis of SA readers' additions and subtractions to their portfolios over the past week shows. Readers also added a host of recent IPO stocks to their port...
Previous 10 Next 10